Cholesterol medication may reduce COVID-19 severity
Researchers have confirmed that statin medication lowers the risk of in-hospital death from COVID-19, following a new study.
In a new study from the University of California San Diego School of Medicine, researchers have discovered that patients taking statin medications, commonly used to reduce blood cholesterol levels, had a 41 percent lower risk of in-hospital death from COVID-19.
Using data from the American Heart Association’s COVID-19 Cardiovascular Disease Registry, the team analysed the medical records of 10,541 hospitalised COVID-19 patients over a nine-month period (January-September 2020) at 104 different hospitals.
Lori Daniels, MD, professor and director of the Cardiovascular Intensive Care Unit at UC San Diego Health and lead study author, said: “When faced with this virus at the beginning of the pandemic, there was a lot of speculation surrounding certain medications that affect the body’s ACE2 receptor, including statins, and whether they may influence COVID-19 risk.”
Statins
“At the time, we thought that statins may inhibit SARS-CoV-2 infection through their known anti-inflammatory effects and binding capabilities, which could potentially stop progression of the virus. From this data, we performed more advanced analyses as we attempted to control for coexisting medical conditions, socioeconomic status and hospital factors,” said Daniels. “In doing so, we confirmed our prior findings that statins are associated with a reduced risk of death from COVID-19 among patients hospitalised for COVID-19.”
“We matched each patient to one or more similar patients, using hospital site, month of admission, age, race, ethnicity, gender, and a list of pre-existing conditions, in order to make the two groups as comparable as possible” added Karen Messer, PhD, study co-author and professor of biostatistics at UC San Diego School of Medicine.
“As with any observational study, we cannot say for certain that the associations we describe between statin use and reduced severity of COVID-19 infection are definitely due to the statins themselves; however, we can now say with very strong evidence that they may play a role in substantially lowering a patient’s risk of death from COVID-19,” Daniels concludes. “We hope that our research findings are an incentive for patients to continue with their medication.”
See more here: openaccessgovernment.org
Header image: Roger Ashford
Please Donate Below To Support Our Ongoing Work To Expose The Lies About COVID19
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.
sir_isO
| #
That’s strange, just earlier I read it’s associated with worse issues.
Here’s an exerpt from Mercola…
“Statins Increase Death Risk From COVID-19
The risks to brain health are only one red flag tied to statins. A concerning link was also uncovered among statins, diabetes and an increased risk of severe disease from COVID-19.21 Among patients with Type 2 diabetes admitted to a hospital for COVID-19, those taking statins had significantly higher mortality rates from COVID-19 within seven days and 28 days compared to those not taking the drugs.
The researchers acknowledged those taking statins were older, more frequently male and often had more comorbidities, including high blood pressure, heart failure and complications of diabetes. However, despite the limitations, the researchers found enough evidence in the over 2,400 participants to conclude:22
“… our present results do not support the hypothesis of a protective role of routine statin use against COVID-19, at least not in hospitalized patients with T2DM (Type 2 diabetes mellitus).
Indeed, the potentially deleterious effects of routine statin treatment on COVID-19-related mortality demands further investigation and, as recently highlighted, only appropriately designed and powered randomized controlled trials will be able to properly address this important issue.”
Statins Double — or Triple — Diabetes Risk
A connection already exists between statins and diabetes, to the extent that people who take statins are more than twice as likely to be diagnosed with diabetes than those who do not, and those who take the drugs for longer than two years have more than triple the risk.23,24”
https://nexusnewsfeed.com/article/health-healing/statins-double-risk-of-dementia-are-linked-to-covid-deaths
Reply
JaKo
| #
Dear Sir-,
I thought it was obvious, particularly to you, that EVERYTHING associated with this covidism IS UNTRUTH. And, as in particular/individual cases, only the degree of divergence from the truth differs.
Cheers, JaKo
Reply
sir_isO
| #
“I thought it was obvious, particularly to you, that EVERYTHING associated with this covidism IS UNTRUTH.”
Sure, and I also noticed all of that untruth seems to revolve around selling toxic “medications” in one form or another…so I just posted something counter to the marketing.
As I understand it, statins are things I would always avoid. It joins a long list of…well, any marketed pharma.
Reply
RabbleRouser
| #
In other words; significant decline in cholesterol drug use requires a “rebranding” to another “dire need” for human survival, to hawk pharma poisons.
Reply
Tom
| #
Not buying it for a minute. Anything to get more people hooked on killer statins. After 30-40 years of pushing statins like candy, why is heart disease still the number one killer in the US? Statins are not making one iota of difference and deaths from heart disease continue to rise.
Reply
sir_isO
| #
From my understanding, statins result in additional damage to the damage by stupid “cholesterol” marketing, which apparently have been justed lower and lower (with those lower levels being implicated in disease).
It’s like any pharma, address a conflated result based on bullshit.
Reply
sir_isO
| #
*adjusted
Reply